Adjuvant gemcitabine for high-risk breast cancer (BC) patients: Final survival results of the randomized phase III SUCCESS-A study

Authors :: Julia Kathrin Jueckstock
Fabienne Schochter
Matthias W. Beckmann
Bernadette Jaeger
Helmut Forstbauer
Lothar Haeberle
Brigitte Rack
Klaus Friese
Mahdi Rezai
Joern Hilfrich
Harald Sommer
Andreas Schneeweiss
Peter A. Fasching
Georg Heinrich
Susanne Albrecht
Wolfgang Janni
Hans Tesch
Werner Lichtenegger
Thomas W. P. Friedl
Source :: Journal of Clinical Oncology. 32:1010-1010
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: 1010 Background: Gemcitabine (G) has shown to have a relevant single agent efficacy and to improve chemotherapy response to taxanes in advanced BC patients. Aim of this study was to evaluate the ef...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
medicine.disease
Gemcitabine
Surgery
Breast cancer
Internal medicine
medicine
Single agent
business
Adjuvant
Chemotherapy response
medicine.drug

Tools